{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:12:46Z","timestamp":1783732366354,"version":"3.55.0"},"reference-count":32,"publisher":"American Association for Laboratory Animal Science","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Extended-release buprenorphine (Bup-XR) is commonly used to manage postoperative pain in rodents while minimizing stress related to handling. An FDA-indexed Bup-XR formulation is commercially available (Ethiqa XR; Fidelis Animal Health, New Brunswick, NJ) and is indicated for the control of postprocedural pain in multiple species, including rats. Despite its widespread use in multiple rat strains, the safety and efficacy of Bup-XR in the August Copenhagen Irish (ACI) rat strain has not been reported, particularly when it is combined with nonsteroidal anti-inflammatory drugs (NSAIDs) and local anesthetics. In this study, 20 male ACI rats aged 6-13 months underwent a minor surgical procedure involving continuous-release hormone pellet implantation (\u2018pellets\u2019), performed either as a primary implantation or a replacement procedure. All rats were administered Bup-XR (0.65 mg\/kg, SC) before the procedure. They were also administered carprofen (5 mg\/kg, SC) immediately before surgery, as well as bupivacaine (1.8 mg\/kg) as a line block anesthetic along the incision line after surgery. Adverse reactions were observed in all animals within 24 hours of surgery, with marked lethargy being most noticeable. Additional symptoms during the first postoperative week included pica behavior, labored breathing, gastrointestinal distress, self-injurious behavior, and dehydration. Within 9 days of the procedure, 13 of 20 males (65%) either died or were humanely euthanized due to significant welfare concerns. Statistical testing confirmed that neither age, weight, nor replacement pellet surgery was significantly associated with mortality. These findings suggest that the adverse effects observed in this strain of rat postsurgery are associated with the use of Bup-XR, possibly in combination with the other agents.<\/jats:p>","DOI":"10.30802\/aalas-jaalas-26-078","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:30:31Z","timestamp":1783729831000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Mortality Following Extended-Release Buprenorphine, Carprofen, and Bupivacaine Administration in Male ACI Rats (Rattus norvegicus)"],"prefix":"10.30802","author":[{"given":"Kasey L","family":"Mitchell","sequence":"first","affiliation":[{"name":"Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin\u2013Madison, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Mejia","sequence":"additional","affiliation":[{"name":"Comparative Pathology Laboratory, Research Animal Resources and Compliance, University of Wisconsin\u2013Madison, Madison, Wisconsin; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Statistics, School of Computer, Data & Information Sciences, University of Wisconsin\u2013Madison, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carstyn F","family":"Joiner","sequence":"additional","affiliation":[{"name":"Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin\u2013Madison, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin\u2013Madison, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"StatPearls.","article-title":"Buprenorphine","author":"Kumar R","year":"2025","unstructured":"Kumar R, Viswanath O, Saadabadi A. Buprenorphine. In: StatPearls. StatPearls Publishing; 2025."},{"issue":"7","key":"bib2","series-title":"Am J Vet Res.","first-page":"697","article-title":"Evaluation of self-injurious behavior, thermal sensitivity, food intake, fecal output, and pica after injection of three buprenorphine formulations in rats (Rattus norvegicus)","volume":"79","author":"Allen M","year":"2018","unstructured":"Allen M, Johnson RA. Evaluation of self-injurious behavior, thermal sensitivity, food intake, fecal output, and pica after injection of three buprenorphine formulations in rats (Rattus norvegicus). Am J Vet Res. 2018;79(7):697\u2013703."},{"issue":"7","key":"bib3","series-title":"Am J Vet Res.","first-page":"619","article-title":"Evaluation of an improved sustained-release buprenorphine formulation for use in mice","volume":"75","author":"Healy JR","year":"2014","unstructured":"Healy JR, Tonkin JL, Kamarec SR, et al. Evaluation of an improved sustained-release buprenorphine formulation for use in mice. Am J Vet Res. 2014;75(7):619\u2013625."},{"issue":"10","key":"bib4","series-title":"Am J Vet Res.","first-page":"ajvr.24.05.0141","article-title":"Physiologic and behavioral effects of long-acting subcutaneous and transdermal buprenorphine in rats","volume":"85","author":"Collins EJ","year":"2024","unstructured":"Collins EJ, Zhao Q, Baker TL, et al. Physiologic and behavioral effects of long-acting subcutaneous and transdermal buprenorphine in rats. Am J Vet Res. 2024;85(10):ajvr.24.05.0141."},{"issue":"2","key":"bib5","series-title":"Contemp Top Lab Anim Sci.","first-page":"8","article-title":"The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice","volume":"39","author":"Gades NM","year":"2000","unstructured":"Gades NM, Danneman PJ, Wixson SK, et al. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci. 2000;39(2):8\u201313."},{"issue":"1","key":"bib6","series-title":"Contemp Top Lab Anim Sci.","first-page":"21","article-title":"A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats","volume":"40","author":"Gillingham MB","year":"2001","unstructured":"Gillingham MB, Clark MD, Dahly EM, Krugner-Higby LA, Dahly EM. A comparison of two opioid analgesics for relief of visceral pain induced by intestinal resection in rats. Contemp Top Lab Anim Sci. 2001;40(1):21\u201326."},{"issue":"3","key":"bib7","series-title":"J Pharmacol Exp Ther.","first-page":"811","article-title":"Pharmacology of opioid and nonopioid analgesics in chronic pain states","volume":"299","author":"Martin TJ","year":"2001","unstructured":"Martin TJ, Eisenach JC. Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther. 2001;299(3):811\u2013817."},{"issue":"1","key":"bib8","series-title":"Acta Vet Scand.","first-page":"37","article-title":"Buprenorphine in rats: potent analgesic or trigger for fatal side effects?","volume":"64","author":"Reifenrath J","year":"2022","unstructured":"Reifenrath J, Heider M, Kempfert M, et al. Buprenorphine in rats: potent analgesic or trigger for fatal side effects? Acta Vet Scand. 2022;64(1):37."},{"issue":"21","key":"bib9","series-title":"Animals (Basel).","first-page":"3157","article-title":"A retrospective report of carprofen administration as post-operative analgesia reveals negative effects of recommended doses","volume":"14","author":"J\u00e4ckel Z","year":"2024","unstructured":"J\u00e4ckel Z, Ad\u017eemovi\u0107 A, Kloos B, et al. A retrospective report of carprofen administration as post-operative analgesia reveals negative effects of recommended doses. Animals (Basel). 2024;14(21):3157."},{"issue":"4","key":"bib10","series-title":"J Am Assoc Lab Anim Sci.","first-page":"462","article-title":"Pharmacokinetic and histopathologic study of an extended-release, injectable formulation of buprenorphine in Sprague-Dawley rats","volume":"60","author":"Levinson BL","year":"2021","unstructured":"Levinson BL, Leary SL, Bassett BJ, et al. Pharmacokinetic and histopathologic study of an extended-release, injectable formulation of buprenorphine in Sprague-Dawley rats. J Am Assoc Lab Anim Sci. 2021;60(4):462\u2013469."},{"issue":"4","key":"bib11","series-title":"J Am Assoc Lab Anim Sci.","first-page":"1","article-title":"Comparative safety and efficacy of extended-release buprenorphine formulations for mouse reproductive surgeries under tribromoethanol","volume":"64","author":"Gillis-Smith SR","year":"2025","unstructured":"Gillis-Smith SR, Umana E, Chavarria TE, et al. Comparative safety and efficacy of extended-release buprenorphine formulations for mouse reproductive surgeries under tribromoethanol. J Am Assoc Lab Anim Sci. 2025;64(4):1\u201310."},{"key":"bib12","article-title":"Ethiqa XR buprenorphine extended-release injectable suspension: safety & efficacy\u2014proven pain relief","unstructured":"Fidelis Animal Health. Ethiqa XR buprenorphine extended-release injectable suspension: safety & efficacy\u2014proven pain relief. Accessed April 2, 2026. https:\/\/ethiqaxr.com\/efficacy-safety\/."},{"issue":"2","key":"bib13","series-title":"J Am Assoc Lab Anim Sci.","first-page":"198","article-title":"Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats","volume":"50","author":"Foley PL","year":"2011","unstructured":"Foley PL, Liang H, Crichlow AR. Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats. J Am Assoc Lab Anim Sci. 2011;50(2):198\u2013204."},{"issue":"2","key":"bib14","series-title":"Endocr Relat Cancer.","first-page":"239","article-title":"Development and characterization of a novel rat model of estrogen-induced mammary cancer","volume":"22","author":"Dennison KL","year":"2015","unstructured":"Dennison KL, Samanas NB, Harenda QE, et al. Development and characterization of a novel rat model of estrogen-induced mammary cancer. Endocr Relat Cancer. 2015;22(2):239\u2013248."},{"issue":"3","key":"bib15","series-title":"Physiol Genomics.","first-page":"215","article-title":"Rat models of 17\u03b2-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention","volume":"50","author":"Shull JD","year":"2018","unstructured":"Shull JD, Dennison KL, Chack AC, et al. Rat models of 17\u03b2-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention. Physiol Genomics. 2018;50(3):215\u2013234."},{"issue":"2","key":"bib16","series-title":"Brain Res.","first-page":"320","article-title":"Differential neuroendocrine responsiveness to morphine in Lewis, Fischer 344, and ACI inbred rats","volume":"858","author":"Baumann MH","year":"2000","unstructured":"Baumann MH, Elmer GI, Goldberg SR, et al. Differential neuroendocrine responsiveness to morphine in Lewis, Fischer 344, and ACI inbred rats. Brain Res. 2000;858(2):320\u2013326."},{"issue":"3","key":"bib17","series-title":"Lab Anim.","first-page":"213","article-title":"Influence of buprenorphine analgesia on post-operative recovery in two strains of rats","volume":"35","author":"Jablonski P","year":"2001","unstructured":"Jablonski P, Howden BO, Baxter K. Influence of buprenorphine analgesia on post-operative recovery in two strains of rats. Lab Anim. 2001;35(3):213\u2013222."},{"issue":"1","key":"bib18","series-title":"Sci Rep.","first-page":"18691","article-title":"Refining pain management in mice by comparing multimodal analgesia and NSAID monotherapy for neurosurgical procedures","volume":"14","author":"Munk A","year":"2024","unstructured":"Munk A, Philippi V, Buchecker V, et al. Refining pain management in mice by comparing multimodal analgesia and NSAID monotherapy for neurosurgical procedures. Sci Rep. 2024;14(1):18691."},{"issue":"3","key":"bib19","series-title":"Lab Anim.","first-page":"322","article-title":"Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals","volume":"36","author":"Roughan JV","year":"2002","unstructured":"Roughan JV, Flecknell PA. Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals. Lab Anim. 2002;36(3):322\u2013343."},{"issue":"3","key":"bib20","series-title":"Lab Anim Sci.","first-page":"300","article-title":"Pica behavior associated with buprenorphine administration in the rat","volume":"47","author":"Clark JA Jr","year":"1997","unstructured":"Clark JA Jr, Myers PH, Goelz MF, et al. Pica behavior associated with buprenorphine administration in the rat. Lab Anim Sci. 1997;47(3):300\u2013303."},{"issue":"2","key":"bib21","series-title":"Lab Anim.","first-page":"202","article-title":"Adverse effects on growth rates in rats caused by buprenorphine administration","volume":"34","author":"Jacobson C","year":"2000","unstructured":"Jacobson C. Adverse effects on growth rates in rats caused by buprenorphine administration. Lab Anim. 2000;34(2):202\u2013206."},{"issue":"6","key":"bib22","series-title":"Lab Anim (NY).","first-page":"242","article-title":"Association of nausea with buprenorphine analgesia for rats","volume":"46","author":"Sarabia-Estrada R","year":"2017","unstructured":"Sarabia-Estrada R, Cowan A, Tyler BM, et al. Association of nausea with buprenorphine analgesia for rats. Lab Anim (NY). 2017;46(6):242\u2013244."},{"issue":"1","key":"bib23","series-title":"Lab Anim (NY).","first-page":"28","article-title":"Lack of adverse effects during a target animal safety trial of extended-release buprenorphine in Fischer 344 rats","volume":"45","author":"Cowan A","year":"2016","unstructured":"Cowan A, Sarabia-Estrada R, Wilkerson G, et al. Lack of adverse effects during a target animal safety trial of extended-release buprenorphine in Fischer 344 rats. Lab Anim (NY). 2016;45(1):28\u201334."},{"issue":"3","key":"bib24","series-title":"Comp Med.","first-page":"293","article-title":"Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations","volume":"54","author":"Thompson AC","year":"2004","unstructured":"Thompson AC, Kristal MB, Sallaj A, et al. Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations. Comp Med. 2004;54(3):293\u2013300."},{"issue":"1","key":"bib25","series-title":"Am J Emerg Med.","first-page":"109.e1-2","article-title":"Acute urinary retention secondary to buprenorphine administration","volume":"32","author":"Edwards RT","year":"2014","unstructured":"Edwards RT, McCormick-Deaton C, Hosanagar A. Acute urinary retention secondary to buprenorphine administration. Am J Emerg Med. 2014;32(1):109.e1-2."},{"key":"bib26","series-title":"IBRO Neurosci Rep.","first-page":"107","article-title":"Evaluating proxies for motion sickness in rodent","volume":"15","author":"Zhang FX","year":"2023","unstructured":"Zhang FX, Xie XH, Guo ZX, et al. Evaluating proxies for motion sickness in rodent. IBRO Neurosci Rep. 2023;15:107\u2013115."},{"key":"bib27","series-title":"Laboratory Animal Medicine and Management.","article-title":"Biology and medicine of rats","author":"Pritchett KR","year":"2004","unstructured":"Pritchett KR, Corrow BF. Biology and medicine of rats. In: Reuter JD, Suckow MA, eds. Laboratory Animal Medicine and Management. International Veterinary Information Service; 2004."},{"issue":"3","key":"bib28","series-title":"Lab Anim.","first-page":"180","article-title":"The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats","volume":"26","author":"Liles JH","year":"1992","unstructured":"Liles JH, Flecknell PA. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats. Lab Anim. 1992;26(3):180\u2013189."},{"issue":"3","key":"bib29","series-title":"Lab Anim (NY).","first-page":"87","article-title":"Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine","volume":"38","author":"Brennan MP","year":"2009","unstructured":"Brennan MP, Sinusas AJ, Horvath TL, et al. Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine. Lab Anim (NY). 2009;38(3):87\u201393."},{"issue":"11","key":"bib30","series-title":"PLoS One.","first-page":"e0188113","article-title":"Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes?","volume":"12","author":"Hestehave S","year":"2017","unstructured":"Hestehave S, Munro G, Christensen R, et al. Is there a reasonable excuse for not providing post-operative analgesia when using animal models of peripheral neuropathic pain for research purposes? PLoS One. 2017;12(11):e0188113."},{"issue":"1\u20132","key":"bib31","series-title":"Eur J Pharmacol.","first-page":"81","article-title":"Effects of \u03bc-, \u03b4- and \u03ba-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice","volume":"532","author":"Mori T","year":"2006","unstructured":"Mori T, Ito S, Kita T, et al. Effects of \u03bc-, \u03b4- and \u03ba-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice. Eur J Pharmacol. 2006;532(1\u20132):81\u201387."},{"issue":"1","key":"bib32","series-title":"Comp Med.","first-page":"60","article-title":"Evaluation of buprenorphine in a postoperative pain model in rats","volume":"59","author":"Curtin LI","year":"2009","unstructured":"Curtin LI, Grakowsky JA, Suarez M, et al. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med. 2009;59(1):60\u201371."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-078\/article-10.30802-AALAS-JAALAS-26-078.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-078\/article-10.30802-AALAS-JAALAS-26-078.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:30:31Z","timestamp":1783729831000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/aop\/article-10.30802-AALAS-JAALAS-26-078\/article-10.30802-AALAS-JAALAS-26-078.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":32,"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-26-078","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}